CF
VXRT

Cantor Fitzgerald’s Vaxart VXRT Stock Holding History

Cantor Fitzgerald’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,809,238
Closed -$1.36M – 572
2023
Q3 		$1.36M Sell
1,809,238
-5,277,103
-74% -$4.01M 0.04% 249
2023
Q2 		$5.17M Buy
+7,086,341
New +$6.59M 0.12% 196

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Cantor Fitzgerald's VXRT Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Vaxart (VXRT) in Q4 2023, closing a stake of 1,809,238 shares — an estimated $1.36M sold.

Cantor Fitzgerald first reported a position in VXRT in Q2 2023 and held it in 2 quarters. The position peaked at $5.17M in Q2 2023. 87 funds tracked by Wall St. Rank hold VXRT as of Q4 2023.

  • Cantor Fitzgerald reported no remaining Vaxart position as of Q4 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 1,809,238 Vaxart shares in Q4 2023, an estimated $1.36M.
  • Cantor Fitzgerald first reported a position in Vaxart in Q2 2023 and held it in 2 quarters.
  • Cantor Fitzgerald's Vaxart position peaked at $5.17M in Q2 2023.
  • 87 funds tracked by Wall St. Rank held Vaxart as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.